## Note
nid: 1481836462671
model: AnKingOverhaul
tags: #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Neurology::Neuro_Pathology, #AK_Step1_v11::#B&B::13_Infectious_Disease::06_Viruses::02_DNA_Viruses, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Natalizumab, #AK_Step1_v11::#FirstAid::02_Immunology::04_Immunosuppressants::04_Therapeutic_Antibodies::Rituximab, #AK_Step1_v11::#FirstAid::10_Hematology_Oncology::05_Pharm::23_Rituximab, #AK_Step1_v11::#FirstAid::12_Neuro_&_Special_Senses::03_Pathology::18_Other_Demyelinating_&_Dysmyelinating_Disorders::Progressive_Multifocal_Leukoencephalopathy, #AK_Step1_v11::#OME_banner::Basic_Science::08_Microbiology::23_DNA_Viruses, #AK_Step1_v11::#Pathoma::17_Neuro::06_Demyelinating_Disorders, #AK_Step1_v11::#Pathoma::17_Neuro::06_Demyelinating_Disorders::demyelinating_disorders-extra?, #AK_Step1_v11::#Physeo::06_Micro::05_Viruses::11_JC_Virus_&_BK_Virus, #AK_Step1_v11::#Physeo::09_Pharm::17_Hem/Onc_Pharm::Rituximab_Bevacizumab_Alemtuzumab_Cetuximab_Panitumumab_Trastuzmab, #AK_Step1_v11::#Physeo::11_Pathology::05_Neuropathology_Pathology::04_Demyelinating_Disorders, #AK_Step1_v11::#SketchyMicro::03_Viruses::03_DNA::07_JC_polyomavirus,_BK_polyomavirus_(Polyomaviridae), #AK_Step1_v11::^Systems::Neuro::Pathology, #AK_Step2_v11::#B&B::04_Neuro::04_Demyelinating_Disorders::02_Demyelinating_Disorders
markdown: false

### Text
<p dir="ltr" style="margin-top: 0pt; margin-bottom: 0pt;">
<span style=
"background-color: (255, 255, 255);vertical-align: baseline">There
is</span> <span style=
"background-color: (255, 255, 255); vertical-align: baseline;"><u>increased</u></span>
<span style=
"background-color: (255, 255, 255); vertical-align: baseline;">risk
of</span> <span style=
"background-color: (255, 255, 255); vertical-align: baseline;"><b>progressive
multifocal leukoencephalopathy</b></span> <span style=
"background-color: (255, 255, 255); vertical-align: baseline;">in
patients taking</span> <span style=
"background-color: (255, 255, 255); vertical-align: baseline;">{{c1::<b>natalizumab</b>}}</span>
<span style=
"background-color: (255, 255, 255); vertical-align: baseline;">and</span>
<span style=
"background-color: (255, 255, 255); vertical-align: baseline;">{{c2::<b>rituximab</b>}}</span>

### Extra
<div>
  can be used in the treatment of <b>multiple sclerosis</b>
</div>

### Lecture Notes


### Missed Questions


### Pathoma


### Boards and Beyond


### First Aid
<img src="tmpvWTtAy.png"> <img src="tmpKCcQ2r.png">

### Sketchy
<img src="paste-333250807463939.jpg"> <img src=
"paste-07a2ebc4e53e1d074d10147c6ee162d8c94dabca.png"> <a href=
"https://dashboard.sketchy.com/study/medical/courses/medical-microbiology/units/medical-microbiology-viruses/videos/medical-microbiology-viruses-dna-viruses-jc-polyomavirus-bk-polyomavirus-polyomaviridae?utm_source=anki&utm_medium=partnership&utm_campaign=february_update&utm_content=medical">
Watch JC polyomavirus, BK polyomavirus (Polyomaviridae)</a>

### Pixorize


### Physeo


### OME
<div class="ome-widget">
  <a href=
  "https://onlinemeded.org/spa/microbiology/dna-viruses/acquire?ref=anki">
  <img src="_OME_AnkiFlashcards_Lesson_4.png"></a>
</div>

### Additional Resources
<b>Atlas:</b> <img src="tmpyyXiC0.png">

### One by one

